网站主页 >> CAS数据库列表 >> (TYR5,D-TRP6·8·9,LYS-NH210)-NEUROKININ A (4-10)
(TYR5,D-TRP6·8·9,LYS-NH210)-NEUROKININ A (4-10)
|
|
|
- CAS号:
- 135306-85-3
- 英文名:
- H-ASP-TYR-D-TRP-VAL-D-TRP-D-TRP-LYS-NH2
- 英文别名:
- MEN 10376;MEN-10,376 ≥95%;MEN-10,376, ≥95% (HPLC);MEN-10,376 , ≥95% (HPLC);M.W. 1081.24 C57H68N12O10;Neurokinin-2 receptor antagonist;ASP-TYR-D-TRP-VAL-D-TRP-D-TRP-LYS-NH2;H-ASP-TYR-D-TRP-VAL-D-TRP-D-TRP-LYS-NH2;tyr(5)-trp(6,8,9)-lys(10)-neurokinina(4-10;[TYR5, D-TRP6,8,9, LYS10]NEUROKININ A (4-10)
- 中文名:
- (TYR5,D-TRP6·8·9,LYS-NH210)-NEUROKININ A (4-10)
- 中文别名:
- MEN 10376肽
- CBNumber:
- CB5297135
- 分子式:
- C57H68N12O10
- 分子量:
- 1081.22
- MOL File:
- 135306-85-3.mol
|
|
|
(TYR5,D-TRP6·8·9,LYS-NH210)-NEUROKININ A (4-10)化学性质
-
沸点:
-
1555.4±65.0 °C(Predicted)
-
|
-
密度:
-
1.361±0.06 g/cm3(Predicted)
-
|
-
储存条件:
-
-20°C
-
|
-
溶解度:
-
Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
-
|
-
形态:
-
solid
-
|
-
酸度系数(pKa):
-
3.71±0.10(Predicted)
-
|
-
颜色:
-
white
-
|
(TYR5,D-TRP6·8·9,LYS-NH210)-NEUROKININ A (4-10)性质、用途与生产工艺
Men 10376 是一种有效的选择性的 tachykinin NK-2 受体拮抗剂，对大鼠小肠 NK-2 受体的 Ki 值为 4.4 μM。
Ki: 4.4 μM (NK-2 receptor, rat small intestine)
Men 10376 is a selective tachykinin NK-2 receptor, with a K
i
of 4.4 μM, and shows low selectivity for NK-1 and NK-3 receptors (K
i
, >10 μM). Men 10376 shows pA
2
s of 5.66 and 8.08 for NK-1 (guinea-pig ileum) and NK-2 receptors (endothelium-deprived rabbit pulmonary artery). Men 10376 shows no effect on NK-3 receptor (K
i
, >10 μM).
Men 10376 (1 and 3 μmol/kg) antagonizes increase in bladder motility produced by the NK-2 receptor agonist in rats.
(TYR5,D-TRP6·8·9,LYS-NH210)-NEUROKININ A (4-10)
上下游产品信息
上游原料
下游产品
(TYR5,D-TRP6·8·9,LYS-NH210)-NEUROKININ A (4-10)
生产厂家
135306-85-3, (TYR5,D-TRP6·8·9,LYS-NH210)-NEUROKININ A (4-10) 相关搜索:
- Peptide
- Tachykinin receptor
- Tachykinins
- Peptides for Cell Biology
- Neuropeptides
- AntagonistPeptides for Cell Biology
- 标准品
- 其他生化试剂
- 生化试剂
- 多肽
- BioChemical
- Amino Acids and Peptides
- Biochemicals and Reagents
- Antagonist
- Tachykinins
- Peptides
- C57H68N12O10
- MEN 10376肽
- 135306-85-3
- (Tyr?,D-Trp?·?·?,Lys-NH???)-Neurokinin A (4-10)
- (Tyr5,D-Trp6.8.9,Lys-NH?1?)-Neurokinin A (4-10)
- 3-amino-4-[[1-[[1-[[1-[[1-[[1-[(1,6-diamino-1-oxohexan-2-yl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid
- L-Lysinamide, L-α-aspartyl-L-tyrosyl-D-tryptophyl-L-valyl-D-tryptophyl-D-tryptophyl-
- (Tyr5,D-Trp6.8.9,Lys-NH21?)-Neurokinin A (4-10)
- Neurokinin-2 receptor antagonist
- MEN-10,376, ≥95% (HPLC)
- MEN-10,376 , ≥95% (HPLC)
- 3-amino-4-[[1-[[1-[[1-[[1-[[1-[(1,6-diamino-1-oxohexan-2-yl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropa
- L-alpha-Aspartyl-L-tyrosyl-D-tryptophyl-L-valyl-D-tryptophyl-D-tryptophyl-L-lysinamide
- MEN-10,376 ≥95%
- (Tyr5,D-Trp6·8·9,Lys-NH210)-Neurokinin A (4-10)
MEN 10376
- L-Asp-L-Tyr-D-Trp-L-Val-D-Trp-D-Trp-L-Lys-NH2
- M.W. 1081.24 C57H68N12O10
- alpha-neurokinin, fragment 4-10, [Tyr5, Trp6,8,9, Lys10]
- L-Lysinamide, L-a-aspartyl-L-tyrosyl-D-tryptophyl-L-valyl-D-tryptophyl-D-tryptophyl-
- neurokinin A(4-10), Tyr(5)-Trp(6,8,9)-Lys(10)-
- [TYR5 ,D -TRP6,8 9 ,LYS10 ]-ALPHA-NEUROKININ A FRAGMENT 4-10 97%
- MEN-10,376 SYNTHETIC >95% NK2 TACHYKININ RECEPT
- (tyr5,D-trp6,8,9,lys10)-A-neurokinin*fragment 4-1
- tyr(5)-trp(6,8,9)-lys(10)-neurokinina(4-10
- (TYR5,D-TRP6,8,9,LYS-NH(2/10))-NEUROKININ A (4-10)
- [TYR5, D-TRP6,8,9, LYS10]NEUROKININ A (4-10)
- [TYR5,D-TRP6,8 9,LYS10]-ALPHA-NEUROKININ A FRAGMENT 4-10
- ASP-TYR-D-TRP-VAL-D-TRP-D-TRP-LYS-NH2
- H-ASP-TYR-D-TRP-VAL-D-TRP-D-TRP-LYS-NH2
- MEN 10376